Clinical Trials
63 trialsdOCT-pBCC
Vejle Hospital
FORWARD
CareDx
CHRU-WCMC
University Hospital, Lille
Pilot Prospective Study for PET-CT Imaging in Participants With Relapsed/Refractory Acute Leukemias
National Institutes of Health Clinical Center (CC)
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Children's Oncology Group
Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBT
Lanzhou University Second Hospital
CISTO
University of Washington
Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC
Sun Yat-sen University
Salvage Haploidentical HSCT With DLI and Targeted Therapy for R/R AML
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
QiNKT-HSCT
University Hospital Pilsen
retroESGO ov1
European Society of Gynaecological Oncology
TVNIM-AFU
Association Francaise d'Urologie
Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors
Memorial Sloan Kettering Cancer Center
ctDNA for Early Detection of Recurrence in Melanoma
Herlev and Gentofte Hospital
EPOCA
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Financial Distress in Advanced Cancer Patients
M.D. Anderson Cancer Center
HRQL and Symptom Assessment for Patients With DIPG or Recurrent and Re-irradiated Brain Tumours and Their Caregivers
University of Calgary
New MRI Biomarkers in Head and Neck Cancers
Memorial Sloan Kettering Cancer Center
Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry Study
Baylor College of Medicine
Quality of Care for Adolescent and Young Adult (AYA) Patients Living With Serious or Advanced Cancer
National Institutes of Health Clinical Center (CC)
Pituitary Tumor Surveillance: Pathogenic Correlation
Cedars-Sinai Medical Center
Predicting Recurrence in HR+/HER2- Early Breast Cancer
Shengjing Hospital
Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.
University of Washington
Long-term Efficacy of Modified Guilu Erxian Glue for Myasthenia Gravis
Beijing University of Chinese Medicine
Dynamic Individualized Risk Profiling of Patients With Relapsed/Refractory Lymphoid Malignancies and CD19-CAR T Cell Therapy (INTeRCePT 2.0)
University of Zurich
EXOMIC
City of Hope Medical Center
PiloPedia
University Hospital, Angers
IMPACT STREAM
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases
Huazhong University of Science and Technology
Development and Clinical Validation of Early-stage Lung Cancer Prognostic Kit
Chung Shan Medical University
Retro-COSMOS
Tata Memorial Hospital
Clinical-pathological Characterization and Outcomes of Metastatic Urothelial Cancer in Latin America
Latin American Cooperative Oncology Group
EPKEY_HSR
IRCCS San Raffaele
NCG-Compliance
Tata Memorial Hospital
A Real-World Study of Trastuzumab Rezetecan in HER2+ Solid Tumors
Beidahuang Industry Group General Hospital
HFUS-CLEAR
Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
Memorial Sloan Kettering Cancer Center
Special Drug Use-results Surveillance of Tafinlar/Mekinist
Novartis
FIL_MOGA
Fondazione Italiana Linfomi - ETS
Five-year Recurrence After LCME
Gødstrup Hospital
HL-R2-B2
University Hospital, Bordeaux
POCEMON BLUE
Azienda Ospedaliera di Padova
ENLIGHT
City of Hope Medical Center
Can Recurrence of Cancer in the Oropharynx be Detected by Blood Samples?
Rigshospitalet, Denmark
Drug-Eluting Bead-Based Transarterial Chemoembolization (DEB-TACE) as a Local Salvage Therapy for Large Lesions in Relapsed and Refractory Diffuse Large B-Cell Lymphoma
Fujian Medical University
LOBSTER
Pacific Edge Limited
Non Interventional Study to Investigate the Safety and Effectiveness in Patients With Relapsed and Refractory Multiple Myeloma Treated With Elranatamab Under the Actual Use.
Pfizer
SPIRIT
GCS Ramsay Santé pour l'Enseignement et la Recherche
Using Gilteritinib to Keep People With Acute Myeloid Leukemia Cancer-free After a Stem Cell Transplant
Astellas Pharma Inc
Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient Investigation
AstraZeneca